Weed (BUDZ) Change in Account Payables (2010 - 2026)
Weed (BUDZ) recorded quarterly Change in Account Payables of $3028.0 in Q1 2026, up 125.13% quarter-over-quarter from -$12049.0 in Q4 2025, and up 14.01% on a YoY basis from $2656.0 in Q1 2025.
Weed (BUDZ) Change in Account Payables (2010 - 2026) Analysis & Trends
Weed's Change in Account Payables history runs 13 years deep, the most recent figure standing at $3028.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 14.01% year-over-year to $3028.0; the TTM figure through Mar 2026 stood at $12734.0 (down 55.81% YoY), while the FY2025 annual figure was $12362.0, up 177.2% from the prior year.
- Change in Account Payables was $3028.0 for Q1 2026 at Weed, up from -$12049.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $65626.0 in Q4 2022 to a low of -$114911.0 in Q2 2022.
- Historically, Change in Account Payables has averaged -$3700.9 across 5 years, with a median of $1393.0 in 2025.
- Biggest YoY gain for Change in Account Payables was 1411.47% in 2022; the steepest drop was 779.67% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $65626.0 in 2022, then sank by 45.2% to $35960.0 in 2023, then plunged by 190.75% to -$32634.0 in 2024, then jumped by 63.08% to -$12049.0 in 2025, then surged by 125.13% to $3028.0 in 2026.
- The last three Change in Account Payables figures came in at $3028.0 (Q1 2026), -$12049.0 (Q4 2025), and $1393.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Weed | - | - | - | 3,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,028.00 |
| Mar 31, 2026 | 3,028.00 |
| Dec 31, 2025 | -12,049.00 |
| Dec 31, 2025 | -12,049.00 |
| Sep 30, 2025 | 1,393.00 |
| Sep 30, 2025 | 1,393.00 |
| Jun 30, 2025 | 20,362.00 |
| Jun 30, 2025 | 20,362.00 |
| Mar 31, 2025 | 2,656.00 |
| Mar 31, 2025 | 2,656.00 |
| Dec 31, 2024 | -32,634.00 |
| Dec 31, 2024 | -32,634.00 |
| Sep 30, 2024 | 23,410.00 |
| Sep 30, 2024 | 23,410.00 |
| Jun 30, 2024 | 35,385.00 |
| Jun 30, 2024 | 35,385.00 |
| Mar 31, 2024 | -42,174.00 |
| Mar 31, 2024 | -42,174.00 |
| Dec 31, 2023 | 35,960.00 |
| Dec 31, 2023 | 35,960.00 |